# A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

> **NCT06602479** · PHASE2 · RECRUITING · sponsor: **AbbVie** · enrollment: 488 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** MEDI0618
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06602479
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-07
- **Primary completion:** 2026-12-18
- **Final completion:** 2027-05-07
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06602479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06602479, "A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06602479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*